RSV Burden Remains High in Young Children in the United States

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 11, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Dec. 11, 2024 -- The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to a study published online Dec. 9 in JAMA Pediatrics.

Heidi L. Moline, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues compared the epidemiology and disease burden of medically attended RSV-associated acute respiratory illness (ARI) among children younger than 5 years during the 2023 to 2024 RSV season with three prepandemic seasons (2017 to 2020). A total of 28,689 children younger than 5 years with medically attended ARI were enrolled: 9,536 during Sept. 1, 2023, through April 30, 2024, and 19,153 during the same calendar period of 2017 to 2020.

The researchers found that among all medically attended episodes, the proportion of children with RSV was 23 percent during 2023 to 2024, which was similar to that seen in 2017 to 2020. RSV-associated hospitalization rates were similar in 2023 to 2024 and 2017 to 2020 -- 5.0 per 1,000 among children younger than 5 years; children aged 0 to 2 months had the highest rates. Assessment of effectiveness of the maternal RSV vaccine was precluded by low uptake. Nirsevimab effectiveness was 89 and 93 percent against medically attended RSV-associated ARI and RSV-associated hospitalization, respectively.

"Results from this analysis document the continued high burden of RSV disease among infants and young children in the U.S. and suggest the potential for substantial public health impact with increased and equitable prevention product coverage in future seasons," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-12 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords